INKON Life: Acquisition of Changsha Kexin completed the industrial and commercial change registration

Zhitong
2025.05.30 13:32

On May 30th, INKON Life announced that the transaction for the acquisition of 51% equity in Changsha Kexin Oncology Hospital Co., Ltd. for RMB 357 million in cash has completed the industrial and commercial change registration procedures. This means that Changsha Kexin has officially become a subsidiary controlled by INKON Life and is included in the company's consolidated financial statements

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer